BioNexus Gene Lab Corp. (BGLC)

USD 2.69

(-3.5%)

Total Assets Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual total assets in 2023 was 11.39 Million USD , up 30.43% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly total assets in 2024 Q2 was 11.13 Million USD , down -0.19% from previous quarter.
  • BioNexus Gene Lab Corp. reported annual total assets of 8.74 Million USD in 2022, down -8.71% from previous year.
  • BioNexus Gene Lab Corp. reported annual total assets of 9.57 Million USD in 2021, down -5.35% from previous year.
  • BioNexus Gene Lab Corp. reported quarterly total assets of 11.16 Million USD for 2024 Q1, down -2.09% from previous quarter.
  • BioNexus Gene Lab Corp. reported quarterly total assets of 7.89 Million USD for 2023 Q2, down -3.51% from previous quarter.

Annual Total Assets Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Total Assets of BioNexus Gene Lab Corp. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 11.39 Million USD 30.43%
2022 8.74 Million USD -8.71%
2021 9.57 Million USD -5.35%
2020 10.11 Million USD 721.56%
2019 1.23 Million USD -25.48%
2018 1.65 Million USD 29.8%
2017 1.27 Million USD 4895592.31%
2016 26.00 USD 0.0%

Peer Total Assets Comparison of BioNexus Gene Lab Corp.

Name Total Assets Total Assets Difference
Aclaris Therapeutics, Inc. 197.4 Million USD 94.225%
Biodesix, Inc. 99.09 Million USD 88.496%
bioAffinity Technologies, Inc. 8.22 Million USD -38.657%
Castle Biosciences, Inc. 477.81 Million USD 97.614%
DarioHealth Corp. 96.38 Million USD 88.173%
Exact Sciences Corporation 6.47 Billion USD 99.824%
IDEXX Laboratories, Inc. 3.25 Billion USD 99.65%
Illumina, Inc. 10.11 Billion USD 99.887%
Intelligent Bio Solutions Inc. 13.77 Million USD 17.266%
iSpecimen Inc. 15.81 Million USD 27.937%
Standard BioTools Inc. 323.06 Million USD 96.471%
23andMe Holding Co. 395.16 Million USD 97.115%
Medpace Holdings, Inc. 1.65 Billion USD 99.312%
NeoGenomics, Inc. 1.68 Billion USD 99.322%
Inotiv, Inc. 856.53 Million USD 98.669%
Psychemedics Corporation 13.27 Million USD 14.093%
Prenetics Global Limited 254.17 Million USD 95.515%
Precipio, Inc. 18.1 Million USD 37.021%
RadNet, Inc. 2.88 Billion USD 99.605%
Sotera Health Company 3.13 Billion USD 99.636%
Star Equity Holdings, Inc. 86.97 Million USD 86.893%
Exagen Inc. 56.94 Million USD 79.981%
Natera, Inc. 1.45 Billion USD 99.218%
Aspira Women's Health Inc. 6.26 Million USD -82.047%
Neogen Corporation 4.58 Billion USD 99.751%
Myriad Genetics, Inc. 1.19 Billion USD 99.049%
ICON Public Limited Company 16.98 Billion USD 99.933%
Bionano Genomics, Inc. 214.4 Million USD 94.683%
CareDx, Inc 484.61 Million USD 97.648%
Check-Cap Ltd. 25.01 Million USD 54.432%
Twist Bioscience Corporation 776.4 Million USD 98.532%
Guardant Health, Inc. 1.78 Billion USD 99.362%
Fulgent Genetics, Inc. 1.27 Billion USD 99.105%
Sera Prognostics, Inc. 95.44 Million USD 88.056%
OPKO Health, Inc. 2.01 Billion USD 99.433%
Personalis, Inc. 225.09 Million USD 94.936%
Applied DNA Sciences, Inc. 13.65 Million USD 16.495%
Star Equity Holdings, Inc. 86.97 Million USD 86.893%
MDxHealth SA 129.13 Million USD 91.172%
Prenetics Global Limited 254.17 Million USD 95.515%
ENDRA Life Sciences Inc. 6.75 Million USD -68.782%
Mainz Biomed B.V. 15.4 Million USD 26.019%
Trinity Biotech plc 59.43 Million USD 80.82%
Neuronetics, Inc. 115.83 Million USD 90.158%
bioAffinity Technologies, Inc. 8.22 Million USD -38.657%